Literature DB >> 27096049

Synthesis and Antiproliferative and Metabolic Evaluations of Novel Securinine Derivatives.

Marc Perez1, Tahar Ayad1, Philippe Maillos2, Valérie Poughon3, Jacques Fahy3, Virginie Ratovelomanana-Vidal1.   

Abstract

New securinine analogues have been prepared by semisynthesis. Two series were developed using either Suzuki or Sonogashira cross coupling reactions. The in vitro cytotoxicity of the compounds was assayed against HCT-116 colon cancer cells. The most potent derivatives showed promising growth inhibition on four tumoral cell lines giving a valuable insight on the structure-activity relationship (SAR) of securinine. Moreover, high antiproliferative effect against A-375 (melanoma) was observed with IC50 up to 60 nM.

Entities:  

Keywords:  Securinine; cytotoxicity; semisynthesis

Year:  2016        PMID: 27096049      PMCID: PMC4834650          DOI: 10.1021/acsmedchemlett.5b00441

Source DB:  PubMed          Journal:  ACS Med Chem Lett        ISSN: 1948-5875            Impact factor:   4.345


  19 in total

1.  [Result of application of securinine in acute poliomyelitis].

Authors:  G R BURAVTSEVA
Journal:  Farmakol Toksikol       Date:  1958 Sep-Oct

2.  Synthesis and biological evaluation of new securinine analogues as potential anticancer agents.

Authors:  Marc Perez; Tahar Ayad; Philippe Maillos; Valérie Poughon; Jacques Fahy; Virginie Ratovelomanana-Vidal
Journal:  Eur J Med Chem       Date:  2016-01-12       Impact factor: 6.514

3.  Acetylenic linkers in lead compounds: a study of the stability of the propargyl-linked antifolates.

Authors:  Wangda Zhou; Kishore Viswanathan; Dennis Hill; Amy C Anderson; Dennis L Wright
Journal:  Drug Metab Dispos       Date:  2012-07-18       Impact factor: 3.922

4.  Letter: Securinine.

Authors:  R Copperman; G Copperman; A D Marderosian
Journal:  JAMA       Date:  1974-04-15       Impact factor: 56.272

5.  Recent advances in Sonogashira reactions.

Authors:  Rafael Chinchilla; Carmen Nájera
Journal:  Chem Soc Rev       Date:  2011-06-08       Impact factor: 54.564

6.  Securinine alkaloids: a new class of GABA receptor antagonist.

Authors:  J A Beutler; E W Karbon; A N Brubaker; R Malik; D R Curtis; S J Enna
Journal:  Brain Res       Date:  1985-03-18       Impact factor: 3.252

7.  Cytotoxic principles of Securinega virosa: virosecurinine and viroallosecurinine and related derivatives.

Authors:  H Tatematsu; M Mori; T H Yang; J J Chang; T T Lee; K H Lee
Journal:  J Pharm Sci       Date:  1991-04       Impact factor: 3.534

8.  Structure and molecular modeling of GABAA receptor antagonists.

Authors:  D Rognan; T Boulanger; R Hoffmann; D P Vercauteren; J M Andre; F Durant; C G Wermuth
Journal:  J Med Chem       Date:  1992-05-29       Impact factor: 7.446

9.  Securinine, a myeloid differentiation agent with therapeutic potential for AML.

Authors:  Kalpana Gupta; Amitabha Chakrabarti; Sonia Rana; Ritu Ramdeo; Bryan L Roth; Munna L Agarwal; William Tse; Mukesh K Agarwal; David N Wald
Journal:  PLoS One       Date:  2011-06-24       Impact factor: 3.240

10.  Structural Elucidation of a Small Molecule Inhibitor of Protein Disulfide Isomerase.

Authors:  Anna Kaplan; Brent R Stockwell
Journal:  ACS Med Chem Lett       Date:  2015-07-29       Impact factor: 4.345

View more
  1 in total

Review 1.  Unique indolizidine alkaloid securinine is a promising scaffold for the development of neuroprotective and antitumor drugs.

Authors:  Sergey Klochkov; Margarita Neganova
Journal:  RSC Adv       Date:  2021-05-26       Impact factor: 4.036

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.